Andrea Harriott, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Migraine Disorders | 11 | 2023 | 1620 | 2.260 |
Why?
|
Cortical Spreading Depression | 6 | 2023 | 276 | 1.680 |
Why?
|
Hyperalgesia | 2 | 2023 | 502 | 1.240 |
Why?
|
Neurons, Afferent | 3 | 2012 | 508 | 0.860 |
Why?
|
Headache Disorders | 2 | 2022 | 128 | 0.860 |
Why?
|
Cluster Headache | 1 | 2022 | 54 | 0.840 |
Why?
|
Facial Pain | 2 | 2015 | 124 | 0.770 |
Why?
|
Dura Mater | 3 | 2012 | 291 | 0.720 |
Why?
|
Brain Ischemia | 4 | 2020 | 3258 | 0.710 |
Why?
|
Headache | 4 | 2022 | 1219 | 0.590 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2016 | 36 | 0.540 |
Why?
|
Infarction, Anterior Cerebral Artery | 1 | 2015 | 12 | 0.530 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2015 | 55 | 0.490 |
Why?
|
Behavior, Animal | 2 | 2020 | 1882 | 0.450 |
Why?
|
Amnesia | 1 | 2015 | 244 | 0.440 |
Why?
|
Models, Animal | 1 | 2019 | 2170 | 0.430 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 46 | 0.420 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2020 | 1016 | 0.420 |
Why?
|
Sumatriptan | 1 | 2012 | 66 | 0.420 |
Why?
|
Skull Base | 1 | 2015 | 299 | 0.420 |
Why?
|
Stroke | 4 | 2022 | 9963 | 0.400 |
Why?
|
Visual Cortex | 2 | 2020 | 1149 | 0.390 |
Why?
|
Auditory Cortex | 1 | 2014 | 346 | 0.380 |
Why?
|
Cysts | 1 | 2015 | 676 | 0.350 |
Why?
|
Masseter Muscle | 2 | 2006 | 36 | 0.340 |
Why?
|
Receptor, Serotonin, 5-HT1D | 1 | 2008 | 9 | 0.330 |
Why?
|
Migraine with Aura | 2 | 2022 | 203 | 0.330 |
Why?
|
Calcium Channels | 1 | 2012 | 621 | 0.320 |
Why?
|
Circle of Willis | 1 | 2008 | 68 | 0.320 |
Why?
|
Tryptamines | 1 | 2008 | 88 | 0.310 |
Why?
|
Carotid Artery, Common | 1 | 2008 | 183 | 0.300 |
Why?
|
Anxiety | 1 | 2020 | 4279 | 0.270 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5705 | 0.270 |
Why?
|
Pain Threshold | 2 | 2023 | 585 | 0.270 |
Why?
|
Rats, Sprague-Dawley | 6 | 2023 | 8300 | 0.270 |
Why?
|
Depression | 2 | 2023 | 7733 | 0.250 |
Why?
|
Nerve Fibers | 1 | 2008 | 688 | 0.250 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18006 | 0.240 |
Why?
|
Ion Channels | 1 | 2009 | 1056 | 0.240 |
Why?
|
Action Potentials | 2 | 2009 | 1814 | 0.240 |
Why?
|
Estrus | 1 | 2023 | 82 | 0.230 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2016 | 2099 | 0.230 |
Why?
|
Trigeminal Ganglion | 3 | 2009 | 186 | 0.220 |
Why?
|
Neuralgia | 1 | 2009 | 568 | 0.220 |
Why?
|
Patch-Clamp Techniques | 3 | 2012 | 963 | 0.220 |
Why?
|
Progesterone | 2 | 2023 | 773 | 0.210 |
Why?
|
Rats | 7 | 2023 | 24265 | 0.200 |
Why?
|
Trigeminal Nerve | 1 | 2022 | 249 | 0.190 |
Why?
|
Inflammation Mediators | 1 | 2009 | 1889 | 0.180 |
Why?
|
Foramen Ovale, Patent | 1 | 2022 | 223 | 0.180 |
Why?
|
Sensory Thresholds | 2 | 2014 | 394 | 0.170 |
Why?
|
Moyamoya Disease | 1 | 2021 | 237 | 0.160 |
Why?
|
Receptors, Colony-Stimulating Factor | 1 | 2018 | 49 | 0.160 |
Why?
|
Afferent Pathways | 2 | 2009 | 302 | 0.150 |
Why?
|
Animals | 15 | 2023 | 168561 | 0.150 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2017 | 42 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 485 | 0.150 |
Why?
|
Leukoaraiosis | 1 | 2018 | 120 | 0.140 |
Why?
|
Headache Disorders, Secondary | 1 | 2016 | 35 | 0.140 |
Why?
|
Estradiol | 1 | 2023 | 2021 | 0.130 |
Why?
|
Research Personnel | 1 | 2020 | 573 | 0.130 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4465 | 0.130 |
Why?
|
Leukoencephalopathies | 1 | 2018 | 238 | 0.130 |
Why?
|
Cerebral Infarction | 1 | 2020 | 1007 | 0.130 |
Why?
|
Electrical Synapses | 1 | 2014 | 19 | 0.130 |
Why?
|
Inflammation | 3 | 2019 | 10578 | 0.130 |
Why?
|
Sex Distribution | 1 | 2020 | 2295 | 0.130 |
Why?
|
Facial Muscles | 1 | 2015 | 157 | 0.120 |
Why?
|
Photophobia | 1 | 2014 | 67 | 0.120 |
Why?
|
Career Choice | 1 | 2020 | 743 | 0.120 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9735 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1196 | 0.110 |
Why?
|
Diabetes, Gestational | 1 | 2023 | 1184 | 0.110 |
Why?
|
RNA-Binding Protein FUS | 1 | 2013 | 72 | 0.110 |
Why?
|
Noise | 1 | 2014 | 279 | 0.110 |
Why?
|
Electric Stimulation | 2 | 2009 | 1770 | 0.110 |
Why?
|
Light | 2 | 2018 | 1374 | 0.110 |
Why?
|
Neurology | 1 | 2020 | 762 | 0.100 |
Why?
|
Central Nervous System Diseases | 1 | 2016 | 518 | 0.100 |
Why?
|
Essential Tremor | 1 | 2013 | 130 | 0.100 |
Why?
|
Premature Birth | 1 | 2023 | 1713 | 0.090 |
Why?
|
Humans | 21 | 2023 | 742088 | 0.090 |
Why?
|
Cerebrovascular Circulation | 1 | 2020 | 2732 | 0.090 |
Why?
|
Hodgkin Disease | 1 | 2017 | 1413 | 0.090 |
Why?
|
Brain Stem | 1 | 2014 | 844 | 0.090 |
Why?
|
Temporal Muscle | 1 | 2009 | 37 | 0.080 |
Why?
|
Female | 15 | 2023 | 379592 | 0.080 |
Why?
|
Bradykinin | 1 | 2009 | 214 | 0.080 |
Why?
|
Superior Cervical Ganglion | 1 | 2008 | 33 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2018 | 2556 | 0.080 |
Why?
|
Biophysics | 1 | 2009 | 383 | 0.080 |
Why?
|
Serotonin Receptor Agonists | 1 | 2008 | 154 | 0.080 |
Why?
|
Pain | 1 | 2022 | 4961 | 0.070 |
Why?
|
Histamine | 1 | 2009 | 507 | 0.070 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2008 | 375 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3301 | 0.070 |
Why?
|
Exons | 1 | 2013 | 2431 | 0.070 |
Why?
|
Calcitonin | 1 | 2008 | 336 | 0.070 |
Why?
|
Freund's Adjuvant | 1 | 2006 | 139 | 0.070 |
Why?
|
Dinoprostone | 1 | 2009 | 600 | 0.070 |
Why?
|
4-Aminopyridine | 1 | 2006 | 81 | 0.070 |
Why?
|
Phenotype | 1 | 2023 | 16331 | 0.070 |
Why?
|
Potassium Channel Blockers | 1 | 2006 | 171 | 0.070 |
Why?
|
Male | 13 | 2023 | 349538 | 0.070 |
Why?
|
Neural Conduction | 1 | 2006 | 468 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3306 | 0.060 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2006 | 876 | 0.060 |
Why?
|
Protein Precursors | 1 | 2008 | 1154 | 0.060 |
Why?
|
Trigeminal Nuclei | 1 | 2003 | 41 | 0.060 |
Why?
|
Critical Care | 1 | 2016 | 2640 | 0.060 |
Why?
|
Organ Specificity | 1 | 2008 | 2003 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2885 | 0.060 |
Why?
|
Mice | 4 | 2023 | 81045 | 0.060 |
Why?
|
Amino Acids | 1 | 2009 | 1727 | 0.050 |
Why?
|
Glutamates | 1 | 2023 | 398 | 0.050 |
Why?
|
Rotarod Performance Test | 1 | 2020 | 64 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2003 | 575 | 0.050 |
Why?
|
Blotting, Western | 1 | 2008 | 5180 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2014 | 4231 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12958 | 0.040 |
Why?
|
Neurons | 1 | 2019 | 9325 | 0.040 |
Why?
|
Pain Measurement | 1 | 2009 | 3418 | 0.040 |
Why?
|
Middle Aged | 5 | 2018 | 213127 | 0.040 |
Why?
|
Receptors, GABA-A | 1 | 2023 | 627 | 0.040 |
Why?
|
Maze Learning | 1 | 2020 | 478 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 35342 | 0.040 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2018 | 242 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17400 | 0.040 |
Why?
|
Genetic Variation | 1 | 2013 | 6540 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 21821 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2006 | 6365 | 0.040 |
Why?
|
Movement | 1 | 2003 | 1470 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2018 | 57683 | 0.030 |
Why?
|
Estrogens | 1 | 2023 | 1562 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2068 | 0.030 |
Why?
|
Adult | 4 | 2017 | 213712 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2009 | 19223 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2023 | 2795 | 0.030 |
Why?
|
Young Adult | 2 | 2015 | 56350 | 0.030 |
Why?
|
Burnout, Professional | 1 | 2020 | 690 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 12730 | 0.020 |
Why?
|
Aged | 3 | 2018 | 162944 | 0.020 |
Why?
|
Risk Factors | 1 | 2014 | 72145 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2736 | 0.020 |
Why?
|
Signal Transduction | 1 | 2009 | 23387 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6756 | 0.020 |
Why?
|
Jaw | 1 | 2003 | 96 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21719 | 0.010 |
Why?
|
Mutation | 2 | 2018 | 29717 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29087 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53187 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11472 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 62966 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 12071 | 0.000 |
Why?
|